HTEC:NYE-Robo Global® Healthcare Technology and Innovation ETF (USD)

ETF | Health |

Last Closing

USD 29.4713

Change

0.00 (0.00)%

Market Cap

USD 0.06B

Volume

4.97K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

+0.32 (+0.21%)

USD 42.19B
FHLC Fidelity® MSCI Health Care In..

+0.19 (+0.26%)

USD 3.02B
FXH First Trust Health Care AlphaD..

+0.86 (+0.77%)

USD 1.26B
XHE SPDR® S&P Health Care Equipme..

+1.16 (+1.31%)

USD 0.22B
IDNA iShares Genomics Immunology an..

+0.65 (+2.67%)

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF

+1.20 (+3.25%)

USD 0.11B
XHS SPDR® S&P Health Care Service..

+1.71 (+1.78%)

USD 0.08B
BBP Virtus LifeSci Biotech Product..

+1.33 (+2.12%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.96 (+3.42%)

USD 0.01B
IHF iShares U.S. Healthcare Provid..

+0.59 (+1.03%)

N/A

ETFs Containing HTEC

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.14% 48% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.14% 48% F 49% F
Trailing 12 Months  
Capital Gain 3.37% 48% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.37% 48% F 38% F
Trailing 5 Years  
Capital Gain 21.78% 62% D 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.78% 62% D 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 5.48% N/A N/A 58% F
Dividend Return 5.48% N/A N/A 50% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 36.41% N/A N/A 27% F
Risk Adjusted Return 15.06% N/A N/A 36% F
Market Capitalization 0.06B 30% F 21% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.